Intensity Therapeutics, Inc. (INTS) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Patients Enrolled Prior to Funding Pause in INVINCIBLE-3 | 21.00 | FY2026-Q1 |
| Expected Patient Enrollment for INVINCIBLE-4 Study | 54.00 | FY2025-Q2 |
Back to INTS overview · INTS earnings · INTS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.